Skip to content

Boston Scientific BSX Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Abbott logo
AbbottABT
Medtronic logo
MedtronicMDT
Intuitive Surgical logo
Intuitive SurgicalISRG
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Cardinal Health logo
Cardinal HealthCAH
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/E18.8×-34.0×
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's finite-lived intangible assets, accumulated amortization?
Boston Scientific (BSX) reported finite-lived intangible assets, accumulated amortization of $11.7B in Q1 2026.
How has Boston Scientific's finite-lived intangible assets, accumulated amortization changed year-over-year?
Boston Scientific's finite-lived intangible assets, accumulated amortization increased by 8.1% year-over-year, from $10.82B to $11.7B.
What is the long-term trend for Boston Scientific's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), Boston Scientific's finite-lived intangible assets, accumulated amortization has grown at a 8.0% compound annual growth rate (CAGR), from $7.81B to $11.46B.